nodes	percent_of_prediction	percent_of_DWPC	metapath
Alverine—HTR1A—Serotonin receptors—HTR1B—attention deficit hyperactivity disorder	0.0636	0.0675	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0477	0.0507	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0467	0.0496	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0401	0.0426	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0393	0.0417	CbGpPWpGaD
Alverine—HTR1A—Serotonin receptors—HTR2A—attention deficit hyperactivity disorder	0.0362	0.0385	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0283	0.0301	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0272	0.0289	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0263	0.028	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0255	0.0271	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.025	0.0266	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0247	0.0263	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0238	0.0253	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.023	0.0245	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0221	0.0235	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0214	0.0228	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.021	0.0224	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0208	0.0221	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0194	0.0206	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0161	0.0171	CbGpPWpGaD
Alverine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.0156	0.263	CrCbGaD
Alverine—HTR1A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0148	0.0157	CbGpPWpGaD
Alverine—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.0147	0.248	CrCbGaD
Alverine—HTR1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0136	0.0144	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00991	0.0105	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0095	0.0101	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0092	0.00978	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00901	0.00958	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00895	0.00951	CbGpPWpGaD
Alverine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00817	0.138	CrCbGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00817	0.00868	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00788	0.00838	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00772	0.00821	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00759	0.00807	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00759	0.00807	CbGpPWpGaD
Alverine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00709	0.12	CrCbGaD
Alverine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00695	0.118	CrCbGaD
Alverine—HTR1A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00673	0.00715	CbGpPWpGaD
Alverine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00664	0.112	CrCbGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00625	0.00664	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.006	0.00638	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00588	0.00625	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00588	0.00625	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00571	0.00607	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00551	0.00586	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00546	0.0058	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00535	0.00569	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0053	0.00563	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00521	0.00553	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00514	0.00547	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00508	0.00539	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00506	0.00537	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00492	0.00522	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00483	0.00514	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00479	0.00509	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00477	0.00507	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00468	0.00497	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00466	0.00495	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00459	0.00488	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00445	0.00473	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00435	0.00462	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00421	0.00448	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00414	0.0044	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00409	0.00435	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00408	0.00433	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00381	0.00405	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00356	0.00379	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00339	0.0036	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00332	0.00353	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00331	0.00352	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00321	0.00341	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00315	0.00335	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00311	0.00331	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00311	0.00331	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00308	0.00327	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00302	0.00321	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0029	0.00308	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00271	0.00288	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00267	0.00284	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00247	0.00262	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0023	0.00245	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00212	0.00225	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00209	0.00222	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00203	0.00216	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00201	0.00214	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00187	0.00199	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00183	0.00194	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00182	0.00193	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00181	0.00193	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00178	0.00189	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00178	0.00189	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00176	0.00187	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00175	0.00186	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0017	0.00181	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00165	0.00175	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00164	0.00174	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00162	0.00172	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.0016	0.0017	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00149	0.00158	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00124	0.00131	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00122	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00108	0.00115	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.001	0.00107	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000972	0.00103	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000956	0.00102	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000944	0.001	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000879	0.000935	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000616	0.000655	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000326	0.000347	CbGpPWpGaD
